Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Pan G"'
The Phillips Curve and the Federal Reserve: Were the 1999-2000 Interest Rate Hikes Really Necessary.
Autor:
Corrigan, Thomas D., Yatrakis, Pan G.
Publikováno v:
Business Economics. Jul2001, Vol. 36 Issue 3, p33. 7p. 6 Graphs.
Publikováno v:
Clinical Pharmacology & Therapeutics; Mar2016, Vol. 99 Issue 3, p265-268, 4p
Publikováno v:
Clinical Pharmacology & Therapeutics; Sep2013, Vol. 94 Issue 3, p349-358, 10p
Autor:
Pan G; Department of Obstetrics and Gynecology, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, No 26. Shengli Street, Jiang'an District, Wuhan, 430014, Hubei Province, P. R. China.; Key Laboratory for Molecular Diagnosis of Hubei Province, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, P. R. China., Zhang P; Department of Obstetrics and Gynecology, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, No 26. Shengli Street, Jiang'an District, Wuhan, 430014, Hubei Province, P. R. China.; Key Laboratory for Molecular Diagnosis of Hubei Province, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, P. R. China., Li S; Department of Obstetrics and Gynecology, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, No 26. Shengli Street, Jiang'an District, Wuhan, 430014, Hubei Province, P. R. China.; Key Laboratory for Molecular Diagnosis of Hubei Province, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, P. R. China., Cao L; Department of Obstetrics and Gynecology, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, No 26. Shengli Street, Jiang'an District, Wuhan, 430014, Hubei Province, P. R. China.; Key Laboratory for Molecular Diagnosis of Hubei Province, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, P. R. China., Yang C; Department of Obstetrics and Gynecology, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, No 26. Shengli Street, Jiang'an District, Wuhan, 430014, Hubei Province, P. R. China. yangcq1003@163.com.; Key Laboratory for Molecular Diagnosis of Hubei Province, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, P. R. China. yangcq1003@163.com.
Publikováno v:
Journal of health, population, and nutrition [J Health Popul Nutr] 2024 Apr 09; Vol. 43 (1), pp. 50. Date of Electronic Publication: 2024 Apr 09.
Autor:
Cao Y; Department of Epidemiology and Biostatistics, Anhui Medical University, Hefei, Anhui, China., Fang W; Department of Epidemiology and Biostatistics, Anhui Medical University, Hefei, Anhui, China., Chen Y; Department of Epidemiology and Biostatistics, Anhui Medical University, Hefei, Anhui, China., Zhang H; Department of Epidemiology and Biostatistics, Anhui Medical University, Hefei, Anhui, China., Ni R; Department of Epidemiology and Biostatistics, Anhui Medical University, Hefei, Anhui, China., Pan G; Department of Epidemiology and Biostatistics, Anhui Medical University, Hefei, Anhui, China.; Key Laboratory of Population Health Across Life Cycle (Anhui Medical University), Ministry of Education of the People's Republic of China, Hefei, Anhui, China.; Medical Data Processing Center of School of Public Health of Anhui Medical University, Anhui Medical University, Hefei, Anhui, China.
Publikováno v:
Journal of medical virology [J Med Virol] 2024 Feb; Vol. 96 (2), pp. e29419.
Autor:
Mohamoud M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Cheng C; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Ryan D; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Kim I; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Wu E; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Muñoz M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Kortepeter C; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Pinnow E; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Dal Pan G; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Jun; Vol. 113 (6), pp. 1368-1377. Date of Electronic Publication: 2023 Apr 28.
Autor:
Diak IL; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. Ida-Lina.Diak@fda.hhs.gov., Swank K; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., McCartan K; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Beganovic M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Kidd J; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Gada N; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Kapoor R; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Wolf L; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Kangas L; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Wyeth J; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Salvatore T; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Fanari M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., LeBoeuf AA; Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Mishra P; Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Blum MD; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Dal Pan G; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Drug safety [Drug Saf] 2023 Feb; Vol. 46 (2), pp. 145-155. Date of Electronic Publication: 2022 Dec 02.
Autor:
Croteau D; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, MD, 20993, Silver Spring, USA. david.croteau@fda.hhs.gov., Pinnow E; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, MD, 20993, Silver Spring, USA., Wu E; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, MD, 20993, Silver Spring, USA., Muñoz M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, MD, 20993, Silver Spring, USA., Bulatao I; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, MD, 20993, Silver Spring, USA., Dal Pan G; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, MD, 20993, Silver Spring, USA.
Publikováno v:
Drug safety [Drug Saf] 2022 Feb; Vol. 45 (2), pp. 169-180. Date of Electronic Publication: 2022 Feb 03.
Autor:
Cherkaoui S; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Pinnow E; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Bulatao I; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Day B; University of Maryland School of Medicine, University of Maryland, Baltimore, Maryland, USA., Kalaria M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Brajovic S; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Dal Pan G; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Dec; Vol. 110 (6), pp. 1512-1525. Date of Electronic Publication: 2021 Jul 08.
Autor:
Wang L; Janssen Research & Development LLC, Titusville, NJ, USA., Swerdel JN; Janssen Research & Development LLC, Titusville, NJ, USA., Weaver J; Janssen Research & Development LLC, Titusville, NJ, USA., Weiss B; Janssen Research & Development LLC, Spring House, PA, USA., Pan G; Janssen Research & Development LLC, Spring House, PA, USA., Yuan Z; Janssen Research & Development LLC, Titusville, NJ, USA., DiBattiste PM; Janssen Research & Development LLC, Raritan, NJ, USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2021 Aug; Vol. 37 (8), pp. 1275-1281. Date of Electronic Publication: 2021 Apr 23.